Bausch Health Companies Inc. (NYSE:BHC – Get Rating) was the target of some unusual options trading on Wednesday. Stock traders acquired 40,728 call options on the company. This represents an increase of approximately 104% compared to the typical volume of 20,011 call options.
Analyst Upgrades and Downgrades
A number of equities analysts recently weighed in on the company. Truist Financial lowered Bausch Health Companies from a "buy" rating to a "hold" rating in a research report on Thursday, July 28th. Piper Sandler reduced their price objective on Bausch Health Companies from $7.00 to $6.00 and set a "neutral" rating for the company in a research note on Friday, September 9th. Royal Bank of Canada increased their price objective on Bausch Health Companies from $4.50 to $8.00 and gave the stock a "sector perform" rating in a research note on Thursday, September 1st. Finally, JPMorgan Chase & Co. downgraded Bausch Health Companies from an "overweight" rating to a "neutral" rating in a research note on Thursday, July 28th. Six analysts have rated the stock with a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $10.60.
Get Bausch Health Companies alerts:Institutional Trading of Bausch Health Companies
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Blueshift Asset Management LLC acquired a new stake in shares of Bausch Health Companies during the 1st quarter worth approximately $464,000. Metis Global Partners LLC acquired a new stake in shares of Bausch Health Companies during the 1st quarter worth approximately $254,000. Woodline Partners LP grew its holdings in shares of Bausch Health Companies by 1.1% during the 1st quarter. Woodline Partners LP now owns 1,013,462 shares of the company's stock worth $23,158,000 after purchasing an additional 10,944 shares in the last quarter. Guardian Capital Advisors LP grew its holdings in shares of Bausch Health Companies by 73.8% during the 1st quarter. Guardian Capital Advisors LP now owns 63,690 shares of the company's stock worth $1,447,000 after purchasing an additional 27,040 shares in the last quarter. Finally, Crescent Park Management L.P. acquired a new stake in shares of Bausch Health Companies during the 1st quarter worth approximately $5,257,000. Institutional investors and hedge funds own 70.07% of the company's stock.
Bausch Health Companies Stock Performance
Shares of BHC stock traded up $0.31 during trading on Wednesday, reaching $7.47. The company had a trading volume of 5,205,571 shares, compared to its average volume of 6,796,660. The company has a market capitalization of $2.70 billion, a PE ratio of 62.26 and a beta of 1.21. The firm's 50 day simple moving average is $6.46 and its two-hundred day simple moving average is $11.81. The company has a debt-to-equity ratio of 85.63, a current ratio of 1.08 and a quick ratio of 0.87. Bausch Health Companies has a one year low of $4.00 and a one year high of $29.31.Bausch Health Companies Company Profile
(Get Rating)
Bausch Health Companies Inc, together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products.
Featured Stories
- Get a free copy of the StockNews.com research report on Bausch Health Companies (BHC)
- Can United Natural Foods Fight Both Inflation and the Fed?
- Mullen Automotive Is Ready To Get In Gear
- Cracker Barrel: A Tasty Treat Or Bad Apple?
- Defensive Stocks For A Volatile Market
- Will UPS Be Next to Deliver a Warning?
Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with MarketBeat.com's FREE daily email newsletter.